MARKET

LIMNW

LIMNW

Liminatus Pharma
NASDAQ
0.0750
+0.0394
+110.67%
After Hours: 0.0355 -0.0395 -52.67% 09:30 06/30 EDT
OPEN
0.0750
PREV CLOSE
0.0356
HIGH
0.0750
LOW
0.0750
VOLUME
1.01K
TURNOVER
--
52 WEEK HIGH
0.3775
52 WEEK LOW
0.0300
MARKET CAP
--
P/E (TTM)
-0.1297
1D
5D
1M
3M
1Y
5Y
1D
Liminatus Pharma Amends InnocsAI Merger Deal, Sets July 2 Closing
Dow Jones · 7h ago
Liminatus Pharma amends, restates merger agreement with InnocsAI
TipRanks · 7h ago
Liminatus Pharma Amends Proposed $320M Merger Deal With InnocsAI As Closing Now Anticipated Before Shareholder Approval On July 2
Benzinga · 7h ago
Liminatus Pharma amends InnocsAI merger terms, targets July 2 close
PUBT · 7h ago
LIMINATUS PHARMA - INNOCSAI EQUITY HOLDERS TO RECEIVE UP TO 19.99% OF LIMINATUS COMMON STOCK
Reuters · 7h ago
Press Release: Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
Dow Jones · 7h ago
Liminatus Pharma announces annual shareholder meeting
PUBT · 18h ago
Weekly Report: what happened at LIMN last week (0622-0626)?
Weekly Report · 1d ago
More
About LIMNW
Iris Acquisition Corp is a Cayman Islands-based blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business nor generates any revenues.

Webull offers Iris Acquisition Corp stock information, including NASDAQ: LIMNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIMNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LIMNW stock methods without spending real money on the virtual paper trading platform.